European Perspective
Abstract: Cancer is a major health concern in the EU. Currently, it is the second largest cause of death in Europe, and, due to the rapidly ageing population, its prevalence is increasing. Cancer is expected to affect one in two people in the future. Given this significant impact on society, policymakers at both the European and national levels have devoted much attention to the battle against cancer. It should be noted, however, that the EU’s leverage within health policy is limited to complementing national policies through coordination or information sharing. By providing a framework for cooperation between national entities, the EU promotes efficient research and development, propagates best practices regarding cancer prevention and treatment, encourages information exchange, and regulates the use of carcinogenic substances. It facilitates coordination and cooperation by bringing stakeholders together and harmonizing the cancer policy between member states. The European quality assurance scheme for breast cancer services (the ‘European QA scheme’) covers the entire pathway of care from screening to end-of-life care, and it is person-centred and evidence-based. The European QA scheme is being developed for European countries, but its use, implementation, and impact may extend beyond geographic boundaries.